Aller au contenu principal
Revenir au programme

Session 29

World Industry Tribune
vendredi 29 janvier 2016
16:00 à 19:00
room 1
FORUM ÉCONOMIQUE

Modérateur(s)

Dr Benjamin ASCHER
Chirurgien Plasticien
France
Laurent BRONES
Industriel
France
Thierry CHIGNON
Finance - Capital-investissement
France
Jean Yves COSTE
Industriel
France
Dr Steven H DAYAN
Chirurgien Plasticien
États-Unis
Pr Mark Steven NESTOR
Dermatologue
États-Unis
Dr Tapan PATEL
Chirurgien
Royaume-Uni

Programme de la session

16:05

Part 1 - Market analysis

16:05

M&A dynamics and valuation trends in medical aesthetics

16:15

Global market analysis for aesthetic EBDs

16:25

Global facial aesthetics: impacts of the illegitimate market

16:35

The digital consumer: challenges and opportunities

16:50

Part 2 - Industry strategy

16:50

Research and innovations as the driving force behind Galderma's product portfolio

17:00

The new Allergan, leading the way in growth pharma

17:10

How does Merz cross-fertilize its Ulthera acquisition with its medical aesthetics division

17:20

The role of EBDs in the global medical aesthetic market

17:40

Part 3 - Round table on the laser, EBD & cosmeceutic markets

17:40

Panel industry - Syneron

17:40

Panel industry - Zeltiq

17:40

Panel industry - Skinceuticals

17:40

Panel industry - Thermi

17:40

Panel industry - Filorga

18:10

Part 4 - Round table on the injectable market

18:10

Panel industry - Galderma

18:10

Panel industry - Merz Pharma

18:10

Panel industry - Vivacy Laboratories

18:10

Panel industry - Allergan

18:10

Panel industry - Croma Pharma

18:10

Panel industry - Sinclair Pharma

18:10

Panel industry - Teoxane Laboratories

18:50

Questions & answers

19:00

Sessions à ne pas manquer

Vous avez une question ?

Traitement en cours, veuillez patienter...

Erreur

Veuillez remplir tous les champs requis. Voici les champs manquants :